Risk Factors for Avascular Necrosis of Bone in Patients with Systemic Lupus Erythematosus: is There a Role for Antiphospholipid Antibodies?

Overview

Journal Ann Rheum Dis

Specialty Rheumatology

Date 2000 Jun 2

PMID 10834864

Citations 30

Authors

M Y Mok

V T Farewell

D A Isenberg

Affiliations

Soon will be listed here.

Abstract

Background: Avascular necrosis of bone (AVN) is a well known complication in patients with systemic lupus erythematosus (SLE).

Objective: To investigate the role of antiphospholipid antibody status (IgM and IgG anticardiolipin antibodies and lupus anticoagulant) with adjustment for corticosteroid use as risk factors for the development of AVN.

Methods: A cohort of 265 patients receiving long term follow up in our SLE clinic from 1978 to 1998 was analysed. Patients with AVN complications were detected and then matched for age, sex, ethnicity, duration of disease, and organ disease with two other patients with SLE. A further 31 patients were chosen at random for the analysis.

Results: Eleven patients had AVN, giving a point prevalence of 4%. There were no significant differences demonstrable in the presence of individual antiphospholipid antibodies (aPL) or their combination between the group with AVN or the two control groups.

Conclusion: Incorporating an adjustment for corticosteroid use we were unable to show a link between the presence of aPL and the development of AVN in patients with SLE.

Citing Articles

Osteonecrosis following Steroid Therapy in COVID-19 Patients: An Outlook on the Emerging Problem.

George J, Gautam D, Dominic M, Malhotra R Hip Pelvis. 2025; 37(1):26-37.

PMID: 40012145 PMC: 11885787. DOI: 10.5371/hp.2025.37.1.26.

The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.

Hou R, Lei J, Xue D, Jing Y, Mi L, Guo Q Front Immunol. 2024; 15:1288234.

PMID: 38384449 PMC: 10879316. DOI: 10.3389/fimmu.2024.1288234.

Screening for Asymptomatic Osteonecrosis of the Hip in Systemic Lupus Erythematous: A Systematic Review and Meta-Analysis of MRI-Based Prevalence.

Ibad H, Ghotbi E, Kasaeian A, Levin A, Jones L, Anzai Y Diagnostics (Basel). 2024; 14(3).

PMID: 38337795 PMC: 10855524. DOI: 10.3390/diagnostics14030279.

Symptomatic femoral head necrosis in patients with rheumatoid arthritis: A retrospective case-control study.

Wei Q, Yan Q, Lin D, Gao F, Lin H, Chen Z Immun Inflamm Dis. 2022; 10(6):e633.

PMID: 35634962 PMC: 9091993. DOI: 10.1002/iid3.633.

Epidemiology and risk factors associated with avascular necrosis in patients with autoimmune diseases: a nationwide study.

Tsai H, Chang J, Lu J, Liu C Korean J Intern Med. 2022; 37(4):864-876.

PMID: 35236014 PMC: 9271726. DOI: 10.3904/kjim.2020.098.

References

Goldie I, Tibblin G, Scheller S . Systemic lupus erythematosus (SLE) and aseptic bone necrosis. A discussion based on the presentation of one case treated with corticosteroids. Acta Med Scand. 1967; 182(1):55-63. View

Nagasawa K, Ishii Y, Mayumi T, Tada Y, Ueda A, Yamauchi Y . Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis. 1989; 48(8):672-6. PMC: 1003845. DOI: 10.1136/ard.48.8.672. View

Mok C, Lau C, Wong R . Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol. 1998; 37(8):895-900. DOI: 10.1093/rheumatology/37.8.895. View

Smith F, Sweet D, Brunner C, Davis 4th J . Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis. 1976; 35(3):227-32. PMC: 1006545. DOI: 10.1136/ard.35.3.227. View

Vela P, Batlle E, Salas E, Marco P . Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol. 1991; 9(5):545-6. View

Ruderman M, McCarty Jr D . ARTHRITIS ROUNDS. (4). ASEPTIC NECROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS. REPORT OF A CASE INVOLVING SIX JOINTS. Arthritis Rheum. 1964; 7:709-17. DOI: 10.1002/art.1780070611. View

Murray W . Hip problems associated with organ transplants. Clin Orthop Relat Res. 1973; (90):57-69. View

Zizic T, Marcoux C, Hungerford D, Dansereau J, STEVENS M . Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985; 79(5):596-604. DOI: 10.1016/0002-9343(85)90057-9. View

Seleznick M, Silveira L, Espinoza L . Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 1991; 18(9):1416-7. View

10.

Alijotas J, Argemi M, Barquinero J . Kienböck's disease and antiphospholipid antibodies. Clin Exp Rheumatol. 1990; 8(3):297-8. View

11.

Darlington L . Osteonecrosis at multiple sites in a patient with systemic lupus erythematosus. Ann Rheum Dis. 1985; 44(1):65-6. PMC: 1001570. DOI: 10.1136/ard.44.1.65. View

12.

Felson D, Anderson J . Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987; 1(8538):902-6. DOI: 10.1016/s0140-6736(87)92870-4. View

13.

JAFFE H . Ischemic necrosis of bone. Med Radiogr Photogr. 1969; 45(3):58-86. View

14.

Migliaresi S, Picillo U, Ambrosone L, Di Palma G, Mallozzi M, Tesone E . Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus. 1994; 3(1):37-41. DOI: 10.1177/096120339400300108. View

15.

Mont M, Glueck C, Pacheco I, Wang P, Hungerford D, Petri M . Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997; 24(4):654-62. View

16.

Klipper A, STEVENS M, Zizic T, Hungerford D . Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore). 1976; 55(3):251-7. DOI: 10.1097/00005792-197605000-00004. View

17.

de Graaf P, van Hooff J, Boekhout M, Achterberg J, Pauwels E, Kalff M . Hyperparathyroidism and avascular necrosis of bone after kidney transplantation. A retrospective study of 170 transplant recipients. Neth J Med. 1982; 25(7):230-6. View

18.

Harrington K, Murray W, Kountz S, Belzer F . Avascular necrosis of bone after renal transplantation. J Bone Joint Surg Am. 1971; 53(2):203-15. View

19.

Asherson R, Liote F, Page B, Meyer O, Buchanan N, Khamashta M . Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol. 1993; 20(2):284-8. View

20.

Abeles M, Urman J, Rothfield N . Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med. 1978; 138(5):750-4. View